Viking Thera (VKTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 24,779 | 8,988 | 3,076 | 769 | 756 |
| Marketable Securities | 276,741 | 11,587 | 10,075 | 13,336 | N/A |
| TOTAL | $302,133 | $21,851 | $13,975 | $15,202 | $774 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 179 | 270 | 561 | 238 | 2,270 |
| TOTAL | $179 | $270 | $561 | $238 | $2,270 |
| Total Assets | $302,312 | $22,121 | $14,536 | $15,439 | $3,043 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 3,451 | 3,270 | N/A | 304 |
| Accounts payable and accrued liabilities | 959 | 1,529 | 1,204 | 592 | 1,831 |
| Accrued Expenses | N/A | 22 | 35 | N/A | 19,943 |
| Other current liabilities | N/A | 1,398 | 731 | N/A | 59 |
| TOTAL | $4,550 | $8,657 | $6,477 | $1,977 | $22,517 |
| Non-Current Liabilities | |||||
| aiOther Non-Current Liabilities | 0 | 0 | 0 | 4,706 | 2,655 |
| TOTAL | $N/A | $N/A | $16 | $4,737 | $2,655 |
| Total Liabilities | $4,562 | $8,657 | $6,493 | $6,714 | $25,172 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 71,986 | 50,899 | 23,825 | 9,684 | N/A |
| Common Shares | 1 | N/A | 0 | 0 | 0 |
| Retained earnings | -102,918 | -80,855 | -60,277 | -45,545 | -22,142 |
| Other shareholders' equity | -423 | -20 | -7 | -7 | 0 |
| TOTAL | $297,750 | $13,464 | $8,043 | $8,725 | $-22,129 |
| Total Liabilities And Equity | $302,312 | $22,121 | $14,536 | $15,439 | $3,043 |